The expression levels of PIWIL1, NEGR1, and BCAS3 did not significantly affect the probability of survival when analyzed in the full cohort of CRC patients and controls (p > 0.05; Figure S3). This evidence concerns the gene BCAS3 and colorectal carcinoma.